The INDUCE-seq™ platform is a game changing #technology for the development of advanced #therapies that are safer by design, but what is it? Watch this video to learn how the platform precisely characterizes and maps DNA double-strand breaks using Next Generation Sequencing. Leveraging a novel PCR-free approach, the platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to unlock new therapeutic targets within the genome and to advance gene editing programs. 🧪 #CellTherapy #GeneTherapy
About us
Broken String Bioscience’s technology platform, INDUCE-seq™, supports the development of cell and gene therapies that are safer by design. INDUCE-seq™, is an NGS-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify the specificity of off-target genetic edits and evaluate the associated genetic outcomes. The platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs.
- Website
-
http://www.brokenstringbio.com
External link for Broken String Biosciences
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Cambridge
- Type
- Privately Held
Locations
-
Primary
BioData Innovation Centre, Wellcome Genome Campus
Cambridge, CB10 1DR, GB
Employees at Broken String Biosciences
-
Robert Paull
Co-Founder & Venture Partner, Lux Capital
-
Anthony Underwood
Head of Bioinformatics at Broken String Biosciences. Using novel genomic analysis to unlock gene therapies.
-
Simon Kerr
-
Patrick van Eijk
Co-founder at Broken String Biosciences Ltd, Honorary Research Fellow at Cardiff University
Updates
-
Exciting news! Our Co-founder and CEO, Felix Dobbs, was honoured with the 'Highly Commended Award for CEO of the Year' at last night's Cambridge Independent Science and Technology Awards ceremony. We extend our heartfelt thanks to the Cambridge Independent for this recognition and are proud to be part of Cambridge's vibrant science and technology community. #GeneEditing #CellandGeneTherapy #CambridgeIndependentAwards
-
We’re very pleased to have made the company spotlight on Illumina Ventures. Have a read here: https://lnkd.in/db2nRH7Z #GeneEditing #CRISPR
-
We’re delighted to announce a partnership with the Francis Crick Institute. This collaboration serves to expand the applications of our DNA break-mapping technology and to also advance understanding of genomic instability in development of the neurodegenerative disease amyotrophic lateral sclerosis (ALS). #ALS Read more here: https://lnkd.in/eZ-MyWEU
-
The INDUCE-seq platform overcomes the limitations of current methods for measuring off-target gene editing. It utilizes a new PCR-free technique to directly detect and measure DNA double-strand breaks through next-generation sequencing (NGS). #GeneEditing #CellandGeneTherapy
-
We're pleased to announce our Co-founder and CSO, Professor Simon Reed is giving a talk at the CRISPR Medicine Conference in just a few minutes. If you're at the conference, catch his talk at stage 2. #CRISPRMed24 #GeneTherapy #GeneEditing
-
We are live at the inaugural CRISPR Medicine Conference! Find us at booth #A-1.1-S, or send us an email on: partnerships@brokenstringbio.com, we’d love to connect with you. #CRISPRMed24 #GeneEditing #CellGeneTherapy
-
Broken String Biosciences reposted this
Happy Earth Day! Broken String Biosciences
-
Less than a month to go till the American Society of Gene & Cell Therapy conference which hosts the largest international gathering of cell and gene therapy professionals. Featuring a full program across four packed days in Baltimore, the conference provides a fantastic opportunity to share insights across the latest scientific research and technologies shaping the field. If you're attending #ASGCT or want to find out more about how Broken String’s INDUCE-seq technology is poised to support development of the next-generation of safe and precise cell and gene therapies, get in touch via email on: partnerships@brokenstringbio.com or find us there at Booth #435! #ASGCT2024 #CellGeneTherapy #GeneEditing
-
Only 12 more days until the CRISPR Medicine Conference hosted by CRISPR Medicine News in #Copenhagen! We’re proud to sponsor this inaugural event that unites European #CRISPR researchers and industry leaders. Join Prof. Simon Reed, Felix Dobbs, Elisa Arthofer and Moyo K from our team for a bustling few days of insightful discussions ranging from innovations in editing tools and delivery, to the latest clinical trial updates. If you’re interested in learning how we at Broken String Biosciences are helping to create the next-generation of safe and precise cell and gene therapies with our INDUCE-seq platform, be sure to stop by our booth A-1.1-S or schedule a meeting with us via email on: partnerships@brokenstringbio.com. We hope to see you there! #GeneTherapy #GeneEditing #CRISPRMED24